Discovery of Novel Potent Reversible and Irreversible Myeloperoxidase Inhibitors using Virtual Screening Procedure (original) (raw)
Evaluation of New Scaffolds of Myeloperoxidase Inhibitors by Rational Design Combined with High-Throughput Virtual Screening
Karim Boudjeltia
Journal of Medicinal Chemistry, 2012
View PDFchevron_right
From Dynamic Combinatorial Chemistry to in Vivo Evaluation of Reversible and Irreversible Myeloperoxidase Inhibitors
Franck Meyer
ACS Medicinal Chemistry Letters, 2016
View PDFchevron_right
Discovery of 2-(6-(5-Chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide (PF-06282999): A Highly Selective Mechanism-Based Myeloperoxidase Inhibitor for the Treatment of Cardiovascular Diseases
raman sharma
Journal of medicinal chemistry, 2015
View PDFchevron_right
Novel bis-arylalkylamines as myeloperoxidase inhibitors: Design, synthesis, and structure-activity relationship study
Pierre Van Antwerpen
European Journal of Medicinal Chemistry, 2016
View PDFchevron_right
Structure-Based Design, Synthesis, and Pharmacological Evaluation of 3-(Aminoalkyl)-5-fluoroindoles as Myeloperoxidase Inhibitors
Pierre Van Antwerpen
Journal of Medicinal Chemistry, 2010
View PDFchevron_right
Inhibition of myeloperoxidase: Evaluation of 2H-indazoles and 1H-indazolones
Makhluf Haddadin
Bioorganic & Medicinal Chemistry, 2014
View PDFchevron_right
Exploitation of the unusual thermodynamic properties of human myeloperoxidase in inhibitor design
C. Obinger
Biochemical Pharmacology, 2005
View PDFchevron_right
Myeloperoxidase: a target for new drug development?
Ernst Malle
British Journal of Pharmacology, 2007
View PDFchevron_right
Molecular docking studies of 1,3,4 -thiadiazoles as myeloperoxidase inhibitors
annapoorna vadivelu
2021
View PDFchevron_right
Design, synthesis, and structure - Activity relationship studies of novel 3-alkylindole derivatives as selective and highly potent myeloperoxidase inhibitors
Martine Prevost
Journal of Medicinal Chemistry, 2013
View PDFchevron_right
Ordered cleavage of myeloperoxidase ester bonds releases active site heme leading to inactivation of myeloperoxidase by benzoic acid hydrazide analogs
Forrest Smith
Archives of biochemistry and biophysics, 2014
View PDFchevron_right
Potent Reversible Inhibition of Myeloperoxidase by Aromatic Hydroxamates
John Unitt
Journal of Biological Chemistry, 2013
View PDFchevron_right
Inhibition of Myeloperoxidase: A New Therapeutic Target
Nicole Moguilevsky
View PDFchevron_right
Evaluation of Imidazole-Based Compounds as Heme Oxygenase-1 Inhibitors
Rosaria Acquaviva, Maria Modica
Chemical Biology & Drug Design, 2012
View PDFchevron_right
How does binding of imidazole-based inhibitors to heme oxygenase-1 influence their conformation? Insights combining crystal structures and molecular modelling
Jerome De Ruyck
Acta crystallographica Section B, Structural science, crystal engineering and materials, 2015
View PDFchevron_right
A patent review of myeloperoxidase inhibitors for treating chronic inflammatory syndromes (focus on cardiovascular diseases, 2013-2019)
Pierre Van Antwerpen
Expert Opinion on Therapeutic Patents
View PDFchevron_right
ESR and X-ray Structure Investigations on the Binding and Mechanism of Inhibition of the Native State of Myeloperoxidase with Low Molecular Weight Fragments
Balagopalakrishna Chavali
Applied Magnetic Resonance, 2015
View PDFchevron_right
Regulation of the Nitric Oxide Oxidase Activity of Myeloperoxidase by Pharmacological Agents
Zaira Olivas
Biochemical pharmacology, 2017
View PDFchevron_right
Discovery of the first dual inhibitor of the 5-lipoxygenase-activating protein and soluble epoxide hydrolase using pharmacophore-based virtual screening
Daniela Schuster
Scientific Reports
View PDFchevron_right
Fourfold Filtered Statistical/Computational Approach for the Identification of Imidazole Compounds as HO-1 Inhibitors from Natural Products
Agostino Marrazzo
Marine Drugs
View PDFchevron_right
In Vitro and In Silico Screening of 2,4,5-Trisubstituted Imidazole Derivatives as Potential Xanthine Oxidase and Acetylcholinesterase Inhibitors, Antioxidant, and Antiproliferative Agents
ricardo jose henao salazar
Applied Sciences, 2020
View PDFchevron_right
Development and validation of a screening procedure for the assessment of inhibition using a recombinant enzyme
Karim Boudjeltia
Talanta
View PDFchevron_right
Design and In silico Screening of Combinatorial Library of New Herbicidal Analogs of Cycloalka[d]quinazoline-2,4dione−Benzoxazinones Inhibiting Protoporphyrinogen IX Oxidase
Eugene Megnassan
Journal of Pharmaceutical Research International
View PDFchevron_right
EGFR, HER2 target based molecular docking analysis, in vitro screening of 2, 4, 5-trisubstituted imidazole derivatives as potential anti-oxidant and cytotoxic agents
Mamatha Kasula
Journal of Photochemistry and Photobiology B: Biology, 2017
View PDFchevron_right
Computer simulation of the in vitro and in vivo anti-inflammatory activities of dihydropyrimidines acid derivatives through the inhibition of cyclooxygenase-2
Mukund Chorghade
View PDFchevron_right
High-Throughput Screening and Prediction Model Building for Novel Hemozoin Inhibitors Using Physicochemical Properties
Nguyễn Long
Antimicrobial Agents and Chemotherapy, 2016
View PDFchevron_right
Pharmacophore modeling and virtual screening for designing potential 5-Lipoxygenase inhibitors
Aditya Kumar Sharma
Bioorganic & Medicinal Chemistry Letters, 2010
View PDFchevron_right